Latest News and Press Releases

Press Release – No. 53 / 2020Zealand Pharma to participate in upcoming investor conferencesCopenhagen, DK November 11, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...

Press Release – No. 52 / 2020 Zealand Pharma hosts conference call on November 12 at 4 pm CET (10am ET) to present third quarter results for 2020 Copenhagen, DK November 5, 2020 – Zealand Pharma A/S...

Company announcement – No. 51 / 2020 Copenhagen, September 30, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the...

Company announcement – No. 50 / 2020 Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, September 22, 2020 – Zealand...

Company announcement – No. 50 / 2020 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, September 18, 2020 – Zealand Pharma A/S...

Company announcement – No. 49 / 2020 Zealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive program Copenhagen, September 14,...

Company announcement – No. 48 / 2020 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 11, 2020 – Zealand Pharma A/S (“Zealand”)...

Press release – No. 47 / 2020 Zealand Pharma builds Global Medical Affairs function with world-renowned experts Dr. Danilo Verge and Dr. David Kendall, both of whom have decades of experience in the...

Press Release – No. 46 / 2020 Zealand Pharma to participate in upcoming investor conferences Copenhagen, DK September 3, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...

Company announcement – No. 45 / 2020 Total number of shares and voting rights in Zealand Pharma at August 31, 2020 Copenhagen, August 31, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL)...